Log In
BCIQ
Print this Print this
 

BI 860585

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionMammalian target of rapamycin complex 1 (mTORC1) and mTORC2 inhibitor
Molecular Target Mammalian target of rapamycin complex 1 (mTORC1) ; Mammalian target of rapamycin complex 2 (mTORC2)
Mechanism of ActionMammalian target of rapamycin complex 1 (mTORC1) inhibitor; Mammalian target of rapamycin complex 2 (mTORC2) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today